Viatris ‘Actively Launching’ Glucagon As It Looks To Deliver On Pipeline Promise
US-Based Company Rocked By Import Alert At Indore Facility But Upbeat On Prospects
Viatris is beginning to deliver on at least one of its complex generic injectables – long-promised by the US company as part of a deep and differentiated pipeline – as it pledged to provide further details at the firm’s upcoming company investor day.
